Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2021

01-09-2021 | Opioids | Unknown

Risks and benefits of dihydrocodeine reviewed in NZ

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

As part of their review regarding the risks of misuse, abuse or dependence with dihydrocodeine, New Zealand's Medsafe is requesting feedback from healthcare professionals or consumers. A risk-benefit review was suggesting by a recent meeting of the Medicines Adverse Reactions Committee (MARC). …
Literature
Metadata
Title
Risks and benefits of dihydrocodeine reviewed in NZ
Publication date
01-09-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-01523-7

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Hydroxychloroquine/mycophenolate mofetil/prednisone

Clinical study

Serious safety events in children's hospitals in USA

Case report

Immunosuppressants

Clinical study

Increased risk of aripiprazole-related AEs in children with autism

Case report

Antibacterials

Case report

Antivirals